/
COLL
$27.91+$2.45 (+9.53%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$833.5M
32M shares
52-week range
$25.47 – $50.79
10% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change+$7.82
Collegium Pharmaceutical, Inc. Common Stock
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
www.collegiumpharma.com- Employees
- 423
- IPO / List date
- May 7, 2015
- HQ
- STOUGHTON, MA
Held by traders on TradeandTell
No one on the platform currently holds COLL.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,469,449 | $48.6M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded COLL yet.
